Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
Host: Thomas F. Patterson, MD, FACP, FIDSA
\n\n Guest: George Thompson III, MD, FIDSA
\n\n\n \n
The changing epidemiology of invasive fungal infections, ongoing antifungal resistance, drug-drug interactions, and few oral agents leave patients with limited viable treatment options. While the antifungal pipeline has been essentially dry for the past 2 decades, several antifungal drugs are now in late-stage clinical development and poised to address these unmet needs. But take heed: They will need to be treated as precious commodities lest they, too, become ineffective due to resistance.